© Messe Düsseldorf Image: Laboratory centrifuge with opened lid
13:0513:12 19. Nov 2020
13:0513:12 19. Nov 2020 iCal myOrganizer

MLF: Circulating nucleosomes as potential prognostic markers for COVID-19 disease severity

Session Innovative COVID-19 diagnostics

Volition will present the preliminary results of its developmental COVID prognostic test designed to identify individuals at high risk of poor outcome following infection. We have used our Nu.Q(TM) immunoassay approach to identify cell free circulating nucleosomes associated with elevated NETosis in "at risk" individuals. Nucleosome levels correlate with disease severity and prognostic power is being confirmed in longitudinal patient cohorts.